As one of the fastest-growing therapeutic areas, GLP-1 and cardiometabolic studies offer a valuable lens into the future of patient experience. These trials demand continuous engagement beyond scheduled visits, yet many studies still rely on periodic questionnaires and site interactions to understand how participants are doing, especially as patients navigate changing symptoms such as gastrointestinal side effects throughout treatment.Watch this live demonstration to see how Medable creates a connected patient journey by combining eConsent, eCOA, real-time GI symptom tracking, and AI-powered patient summaries. Follow a participant through a cardiometabolic study and discover how continuous patient insights give investigators meaningful context before every interaction, enabling more timely support and better-informed conversations.
Learn how connected digital experiences can reduce operational blind spots, strengthen participant engagement and retention, and help sponsors achieve up to 97% patient adherence.
